1.
Immune Regulatory Function of B Cells
by Mauri, Claudia
Annual review of immunology, 2012-04-23, Vol.30 (1), p.221-241
2.
Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers
by Saito, Takuro
Nature medicine, 2016-06, Vol.22 (6), p.679-684
3.
Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study
by Cimino-Mathews, Ashley, MD
Human pathology, 2013, Vol.44 (10), p.2055-2063
4.
Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma
by Garnelo, Marta Marta
Gut, 2015-12-15, Vol.66 (2), p.342-351
5.
Regulation of Immune Responses by mTOR
by Powell, Jonathan D
Annual review of immunology, 2012-04-23, Vol.30 (1), p.39-68
6.
Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue
by Chaput, N
Gut, 2009-04, Vol.58 (4), p.520-529
7.
A Morphological and Immunophenotypic Map of the Immune Response in Merkel Cell Carcinoma
by Walsh, Noreen M., MD,FRCPC, FRCPath (UK)
Human pathology, 2016, Vol.52, p.190-196
8.
Antigen-specific therapeutic approaches for autoimmunity
by Serra, Pau
Nature biotechnology, 2019-03, Vol.37 (3), p.238-251
9.
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
by Jiang, Peng
Nature medicine, 2018-10, Vol.24 (10), p.1550-1558
10.
PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
by Cimino-Mathews, Ashley, MD
Human pathology, 2015, Vol.47 (1), p.52-63
11.
Interleukin 10-expressing B cells inhibit tumor-infiltrating T cell function and correlate with T cell Tim-3 expression in renal cell carcinoma
by Cai, Chen
Tumor biology, 2015-12-30, Vol.37 (6), p.8209-8218
12.
Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer
by Narayanan, Sumana
Annals of surgical oncology, 2018-05-16, Vol.25 (8), p.2323-2331
13.
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer
by Roberti, Maria Paula
Nature Medicine, 2020-06, Vol.26 (6), p.919-931
14.
Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus
by He, Jing
Nature medicine, 2016-09, Vol.22 (9), p.991-993
15.
Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients
by McDonald, Kerry-Ann
Annals of surgical oncology, 2019-04-08, Vol.26 (7), p.2191-2199
16.
Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity
by Niessl, Julia
Nature medicine, 2020-02, Vol.26 (2), p.222-227
17.
Unraveling the Complex Interplay Between T Cell Metabolism and Function
by Klein Geltink, Ramon I
Annual review of immunology, 2018-04-26, Vol.36 (1), p.461-488
18.
A dynamic COVID-19 immune signature includes associations with poor prognosis
by Laing, Adam G
Nature medicine, 2020-10, Vol.26 (10), p.1623-1635
19.
Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis
by Hill-Cawthorne, Grant A
Journal of neurology, neurosurgery and psychiatry, 2012-03, Vol.83 (3), p.298-304
20.
Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy
by Sharabi, Andrew B, Dr
The lancet oncology, 2015, Vol.16 (13), p.e498-e509
